Atlas Trials

Sumitomo Pharma Switzerland GmbH

15 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Sumitomo Pharma Switzerland GmbH

RecordFirmDate
MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy (NCT05739136)Sumitomo Pharma Switzerland GmbH2025-04-30
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis (NCT05862272)Sumitomo Pharma Switzerland GmbH2023-08-14
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring (NCT05739123)Sumitomo Pharma Switzerland GmbH2023-05-08
Congenital Athymia Patient Registry (NCT05329935)Sumitomo Pharma Switzerland GmbH2022-05-25
Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy (NCT04756037)Sumitomo Pharma Switzerland GmbH2021-03-18
Farber Disease Natural History Study (NCT03233841)Sumitomo Pharma Switzerland GmbH2017-11-22

Track Sumitomo Pharma Switzerland GmbH automatically

Every clearance here is in the API, with alerts when new ones post.